Anita Arsovska

ORCID: 0000-0003-1927-9614
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Stroke Rehabilitation and Recovery
  • Cerebrovascular and Carotid Artery Diseases
  • Vasculitis and related conditions
  • Venous Thromboembolism Diagnosis and Management
  • Cardiovascular Health and Disease Prevention
  • Ocular Diseases and Behçet’s Syndrome
  • Cerebrovascular and genetic disorders
  • Neurological Disorders and Treatments
  • Cerebral Venous Sinus Thrombosis
  • Systemic Lupus Erythematosus Research
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Systemic Sclerosis and Related Diseases
  • Long-Term Effects of COVID-19
  • Connective tissue disorders research
  • Sarcoidosis and Beryllium Toxicity Research
  • Retinal and Optic Conditions
  • COVID-19 and healthcare impacts
  • Hereditary Neurological Disorders
  • Aortic Thrombus and Embolism
  • Mitochondrial Function and Pathology
  • Vascular Malformations Diagnosis and Treatment
  • Vascular Malformations and Hemangiomas
  • Glycogen Storage Diseases and Myoclonus
  • IgG4-Related and Inflammatory Diseases

Saints Cyril and Methodius University of Skopje
2006-2024

University Clinic of Traumatology
2012-2023

University of Ss. Cyril and Methodius in Trnava
2022

Boston Medical Center
2022

Boston University
2022

PHI University Psychiatric Clinic - Skopje
2020-2021

University Radiology
2014-2019

Diana Aguiar de Sousa Arlene Wilkie Bo Norrving Chris Macey Claudio L. Bassetti and 95 more Cristina Tiu Greg Roth Grethe Lunde Hanne Christensen Jens Fiehler Francesca Romana Pezzella Martin Dichgans Melinda B Roaldsen Peter J. Kelly Robert Mikulík Simona Sacco Valeria Caso Urs Fischer Entela Basha Nune S. Yeghiazaryan Stefan Kiechl R.К. Shiraliyeva Peter Vanacker Marija Bender Mihael Tsalta-Mladenov Hrvoje Budinčević Aleš Tomek Georgios Kaponides Helle K. Iversen Jürgen Faiss Janika Kõrv Tiina Sairanen Igor Sibon Alexander Tsiskaridze George Ntaios Georgios Tsivgoulis László Szapáry Bjorn Logi Thorarinsson Joseph Harbison Natan M. Bornstein Danilo Toni Jashari Fisnik Kunduz Karbozova Evija Miglāne Jatužis Dalius Dirk W. Droste Maria Mallia Erakovic Jevto Anita Arsovska Annette Fromm Adam Kobayashi Elsa Azevedo Stanislav Groppa Cristina Tiu Alla Guekht Željko Živanović Vladimír Nosáľ Bojana Žvan Elena López‐Cancio Natàlia Pérez de la Ossa Bo Norrving Krassen Nedeltchev Hubertus JM Vrijhoef Mehmet Akif Topçuoğlu Yuriy Flomin Rubina Ahmed Andrey Shelesko Mentor Petrela Lina Zubalova Rovshan Hasanov Sylvie De Raedt Mahmutbegović Nevena Silva Andonova Zdravka Poljaković Ondřej Škoda Johnsen Søren Paaske Prof. Dr. med. Helmuth Steinmetz Janika Kõrv Tiina Sairanen S.E. Zarikian Denis Nino Lobjanidze Haralambos Milionis Panagiotis Mitsias Gábor Tárkányi Marianne E. Klinke David Tanné Petraglia Luca Boshnjaku Dren Dzhamal Turgumbaev Karelis Guntis Jatužis Dalius Dirk W. Droste Debeljevic Mladen Anita Arsovska Martin Kurz Czlonkowska Anna Zota Eremei Terecoasa Elena Oana Mikhail Martinov D Jovanović

We assessed best available data on access and delivery of acute stroke unit (SU) care, intravenous thrombolysis (IVT) endovascular treatment (EVT) in the European region 2019 2020.We compared national per number inhabitants 100 annual incident first-ever ischaemic strokes (AIIS) 46 countries. Population estimates incidence were based United Nations Global Burden Disease Report 2019, respectively.The estimated mean SUs was 3.68 (95% CI: 2.90-4.45) one million (MIH) with 7/44 countries having...

10.1177/23969873231186042 article EN European Stroke Journal 2023-07-11

Background Current stroke guidelines recommend advanced imaging (computed tomography [CT] perfusion or magnetic resonance imaging) prior to endovascular therapy (EVT) in patients with late presentation of large vessel occlusion. Adherence may be constrained by resources timely access imaging. We sought understand the factors which influence window selection for EVT candidates Methods conducted an international survey from January May 2022. The questions aimed identify and treatment decisions...

10.1161/svin.122.000595 article EN cc-by-nc-nd Stroke Vascular and Interventional Neurology 2022-12-31

Introduction Despite the availability of prevention and therapies stroke, their implementation in clinical practice, even low-cost ones, remains poor. In 2015, European Stroke Organisation (ESO) initiated ESO Enhancing Accelerating Treatment (EAST) program, which aims to improve stroke care quality, primarily Eastern Europe. Here, we describe its methods milestones. Patients The EAST program is using an strategy based on a ‘detecting-understanding-reducing disparities’ conceptual framework:...

10.1177/2396987319897156 article EN European Stroke Journal 2020-01-20

Background and purpose: There is a J‐shaped association between admission glycemia outcome. We designed an intravenous insulin protocol aiming at rapid strict glucose control in hyperglycemic ischaemic stroke patients. Here, we describe the initial experience, safety, efficacy of this to achieve maintain euglycemia first 48 h. Methods: The based on parallel scales for adjustment infusion rate according current change glycemia, which was recommended our unit 4/2007 acute patients with > 6...

10.1111/j.1468-1331.2011.03537.x article EN European Journal of Neurology 2011-10-18

A depression following a stroke (Post Stoke Depression-PSD) is the most common complication of that has negative effect on result after stroke. better definition risk factors disease will provide for prediction and treatment.To research identification PSD, typical Macedonian population, which help in early prediction, timely diagnosis treatment disease?We carried out prospective study order to determine prevalence PSD 100 patients treated at hospital Tetovo. The severity, localisation...

10.3889/oamjms.2018.182 article EN Open Access Macedonian Journal of Medical Sciences 2018-04-24

Stroke Education in the Digital Era organizations like WSO.Health care providers face challenge of rapidly acquiring knowledge not only about advancements stroke but also innovative strategies and technologies to effectively educate support colleagues.The goal is deliver high-quality, concise, accessible, multiplatform, engaging content a diverse ecosystem.Collectively, these e-strategies aim contribute reduction global burden.

10.1161/strokeaha.123.044877 article EN mit Stroke 2024-02-07

Rationale Cerebrovascular diseases associated with pregnancy and postpartum period are uncommon; however, they can have an important impact on health of both women foetus or newborn. Aims To evaluate the frequency, characteristics management cerebrovascular events in pregnant/postpartum women, to clarify pathophysiological mechanisms underlying occurrence these including biomolecular aspects, assess short- long-term global cardiovascular outcome patients, their predictors infant outcome....

10.1177/2396987319893512 article EN European Stroke Journal 2019-12-06

Cerebral venous sinus thrombosis (CVT) is rare cause of cerebrovascular disease. The incidence 0.5% all stroke. majority affected patients are young adults (mean age: 35-40 years) with mild to moderate disabilities. Poor outcome severe disability seen in 13% cases. Early diagnosis and treatment important for good outcomes preventing complications. Treatment options limited mostly based on consensus. NeuroAiD II™ (MLC901; Moleac Pte, Ltd, Singapore) has a potential beneficial role post-stroke...

10.12998/wjcc.v12.i2.346 article EN cc-by-nc World Journal of Clinical Cases 2024-01-10

Abstract Objective : Acetylsalicylic acid (ASA) is the most widely used antiplatelet agent in treating ischemic strokes. ASA resistance varies between populations, from 5% to 60%. We aimed determine prevalence of our population, its association with demographic characteristics, risk factors, and occurrence recurrent stroke (IS). (IST). Methods One hundred consecutive patients primary or IS were prospectively included. Strokes diagnosed computed tomography (CT) magnetic resonance imaging...

10.2478/prilozi-2024-0014 article EN PRILOZI 2024-06-01

BACKGROUND: The World Stroke Academy (WSA), the educational platform of WSO, provides high-quality stroke education to health care professionals worldwide. Understanding learning needs and preferences WSA members is crucial for effective knowledge translation. This study aims (1) assess demographics professional backgrounds members, (2) identify in acquisition, (3) evaluate audience retention during webinars. METHODS: A survey was developed using Qualtrics distributed via email all from May...

10.1161/strokeaha.124.049311 article EN Stroke 2024-12-19

Promoting research to improve stroke prevention, acute care, and recovery is a key mission of the European Stroke Organisation (ESO). networks may increase efficiencies reduce waste in randomised clinical trials treatments. Several countries have established national or regional networks, informal groups registers which serve as foundation for establishing network. To international collaboration on Europe, ESO Trials Network Committee leading development an alliance Alliance (ESOTA)....

10.1177/2396987319845589 article EN European Stroke Journal 2019-05-07

Although post-stroke depression (PSD) is the most common neuro-psychiatric consequence after a stroke there still some obscurity regarding its aetiology and risk factors, which complicates management. A better knowledge of predictors will enable prevention treatment.The aim this work was identification factors for PSD, typical Macedonian population, help in early prediction, timely diagnosis treatment disease.We carried out prospective study at Clinical Hospital Tetovo, Republic Macedonia to...

10.3889/oamjms.2018.201 article EN Open Access Macedonian Journal of Medical Sciences 2018-05-14

The exposure to tobacco smoke could cause bronchoconstriction and acute asthma attack. Smoking asthmatics have an insufficient therapeutic response the standard therapy unsatisfactory improvement of respiratory function. In a randomized parallel study, inhaled fluticasone propionate in dose 250 µg twice per day was determined 38 with mild asthma, smokers nonsmokers. Short-acting ß2 agonist (salbutamol) dosage 0.1 mg/per used as rescue medication when needed. patients, detected positive...

10.33320/maced.pharm.bull.2016.62.02.005 article EN cc-by Macedonian Pharmaceutical Bulletin 2016-01-01

Background To determine the frequency of patients (pts) with autoimmune diseases who developed stroke and to analyse associated risk factors.

10.1097/01.wox.0000412108.50107.ad article EN cc-by-nc-nd World Allergy Organization Journal 2012-02-01

Introduction One of the aims European Stroke Organisation (ESO) is to facilitate academic, multinational clinical stroke research. However, despite examples successful regional and national research networks collaborative groups, there no organisational structure at a level that can Materials methods In project including survey workshop involving researchers in ESO, we sought identify challenges faced by existing networks, define purpose roles any future collaboration, propose an structure....

10.1177/2396987317747456 article EN European Stroke Journal 2017-12-11

Background/Aim. Carotid stenosis is a risk factor for cognitive impairment. The aim of the study was to evaluate degree impairment in patients with asymp-tomatic and symptomatic carotid correlate it presence, location, extent cerebral ischemic lesions. Methods. A prospective analysis 180 aged 50?70 years, divided into three groups (asymptomatic stenosis, controls) made. We assessed demographic characteristics, vascu-lar factors, ultrasound examination arter-ies, computerized tomography (CT),...

10.2298/vsp200502082j article EN cc-by-sa Vojnosanitetski pregled 2020-08-31
Coming Soon ...